TD Waterhouse Canada’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.8K | Buy |
5,631
+2,200
| +64% | +$11.2K | ﹤0.01% | 1247 |
|
|
2025
Q1 | $17.4K | Buy |
3,431
+3,000
| +696% | +$15.2K | ﹤0.01% | 1290 |
|
|
2024
Q4 | $2.91K | Buy |
431
+231
| +116% | +$1.56K | ﹤0.01% | 1648 |
|
|
2024
Q3 | $1.24K | Buy |
200
+100
| +100% | +$618 | ﹤0.01% | 1684 |
|
|
2024
Q2 | $745 | Hold |
100
| – | – | ﹤0.01% | 1745 |
|
|
2024
Q1 | $875 | Hold |
100
| – | – | ﹤0.01% | 1738 |
|
|
2023
Q4 | $1.11K | Hold |
100
| – | – | ﹤0.01% | 1550 |
|
|
2023
Q3 | $717 | Buy |
+100
| New | +$717 | ﹤0.01% | 1575 |
|